Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Cellvizio Laser Connfocal Microscopy

Research Leaders

6 sponsors active, led by University of North Carolina, Chapel Hill

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (1)
Phase 2 (1)
Phase 4 (1)

Trial Status

Completed4

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 4 completed trials

Clinical Trials (4)

Showing 4 of 4 trials
NCT00588939CompletedPrimary

Confocal Laser Microscopy in Non Erosive Reflux Disease

NCT00998244Not ApplicableCompleted

Study to Evaluate the Effect of a Very Low Carbohydrate Diet on Gastroesophageal Reflux Disease

NCT00703534Phase 2Completed

Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) Symptoms

NCT00307944Phase 4CompletedPrimary

Study of Pantoprazole for Sleepiness Associated With Acid Reflux and Sleep Apnea

Showing all 4 trials

Research Network

Common Treatments

  • Cellvizio Laser Connfocal Microscopy1
  • Pantoprazole1
  • Gelusil1
  • Diet Very Low Carb Or Low Fat1
  • Lesogaberan1

Active Sponsors

  • University of North Carolina, Chapel Hill1
  • Wyeth is now a wholly owned subsidiary of Pfizer1
  • Mayo Clinic1
  • AstraZeneca1
  • Takeda Pharmaceuticals North America, Inc.1

Top Investigators

Related Conditions

  • Heartburn2
  • Gerd1
  • Obstructive Sleep Apnea1
  • Gastroesophageal Reflux Disease1
  • Overweight1

Activity Timeline